RENX ENTERPRISES CORP (RENX) Fundamental Analysis & Valuation

NASDAQ:RENXUS78637J2042

Current stock price

0.0951 USD
-0.04 (-31.58%)
At close:
0.0945 USD
0 (-0.63%)
Pre-Market:

This RENX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RENX Profitability Analysis

1.1 Basic Checks

  • RENX had negative earnings in the past year.
  • In the past year RENX has reported a negative cash flow from operations.
RENX Yearly Net Income VS EBIT VS OCF VS FCFRENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

  • The Return On Assets of RENX (-35.91%) is worse than 85.71% of its industry peers.
  • With a Return On Equity value of -758.13%, RENX is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -35.91%
ROE -758.13%
ROIC N/A
ROA(3y)-46.7%
ROA(5y)N/A
ROE(3y)-589.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RENX Yearly ROA, ROE, ROICRENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -500 -1K

1.3 Margins

  • RENX has a Gross Margin (26.39%) which is in line with its industry peers.
  • The Profit Margin and Operating Margin are not available for RENX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RENX Yearly Profit, Operating, Gross MarginsRENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K

0

2. RENX Health Analysis

2.1 Basic Checks

  • RENX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RENX has more shares outstanding
  • The debt/assets ratio for RENX is higher compared to a year ago.
RENX Yearly Shares OutstandingRENX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500K 1M
RENX Yearly Total Debt VS Total AssetsRENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -2.63, we must say that RENX is in the distress zone and has some risk of bankruptcy.
  • RENX has a Altman-Z score of -2.63. This is amonst the worse of the industry: RENX underperforms 84.13% of its industry peers.
  • RENX has a Debt/Equity ratio of 10.99. This is a high value indicating a heavy dependency on external financing.
  • RENX has a worse Debt to Equity ratio (10.99) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.99
Debt/FCF N/A
Altman-Z -2.63
ROIC/WACCN/A
WACC7.44%
RENX Yearly LT Debt VS Equity VS FCFRENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

  • RENX has a Current Ratio of 0.10. This is a bad value and indicates that RENX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RENX has a Current ratio of 0.10. This is amonst the worse of the industry: RENX underperforms 92.06% of its industry peers.
  • A Quick Ratio of 0.07 indicates that RENX may have some problems paying its short term obligations.
  • RENX's Quick ratio of 0.07 is on the low side compared to the rest of the industry. RENX is outperformed by 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.07
RENX Yearly Current Assets VS Current LiabilitesRENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. RENX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 73.63% over the past year.
  • The Revenue has grown by 2769.98% in the past year. This is a very strong growth!
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.32%
Revenue 1Y (TTM)2769.98%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4229.68%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RENX Yearly Revenue VS EstimatesRENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 50K 100K 150K 200K

0

4. RENX Valuation Analysis

4.1 Price/Earnings Ratio

  • RENX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RENX Price Earnings VS Forward Price EarningsRENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RENX Per share dataRENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. RENX Dividend Analysis

5.1 Amount

  • RENX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

RENX Fundamentals: All Metrics, Ratios and Statistics

RENX ENTERPRISES CORP

NASDAQ:RENX (3/24/2026, 8:00:02 PM)

Premarket: 0.0945 0 (-0.63%)

0.0951

-0.04 (-31.58%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.78%
Inst Owner ChangeN/A
Ins Owners42.77%
Ins Owner ChangeN/A
Market Cap4.41M
Revenue(TTM)4.97M
Net Income(TTM)-13.78M
AnalystsN/A
Price TargetN/A
Short Float %3.33%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 2.42
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.34
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.11
BVpS0.04
TBVpS-0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.91%
ROE -758.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.39%
FCFM N/A
ROA(3y)-46.7%
ROA(5y)N/A
ROE(3y)-589.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 10.99
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 126.45%
Cap/Sales 16.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.07
Altman-Z -2.63
F-Score5
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2769.98%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4229.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.73%
OCF growth 3YN/A
OCF growth 5YN/A

RENX ENTERPRISES CORP / RENX Fundamental Analysis FAQ

What is the fundamental rating for RENX stock?

ChartMill assigns a fundamental rating of 0 / 10 to RENX.


What is the valuation status for RENX stock?

ChartMill assigns a valuation rating of 0 / 10 to RENX ENTERPRISES CORP (RENX). This can be considered as Overvalued.


What is the profitability of RENX stock?

RENX ENTERPRISES CORP (RENX) has a profitability rating of 0 / 10.